Showing results (81-90 of 226) with videos related to
Sort By:
Pageof 23
BJOG : an International Journal of Obstetrics and Gynaecology|December 31, 2002
Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancyN J Sebire, R A Fisher, M Foskett, et al.Anti-Cancer Drug Design|September 29, 1999
Antitumour imidazotetrazines. Part 37. Conjugation of the DNA major-groove alkylating imidazotetrazine mitozolomide to peptide motifs recognizing the minor grooveJ Arrowsmith, S Missailidis, M F StevensBritish Journal of Obstetrics and Gynaecology|January 1, 1986
Developments in chemotherapy for medium- and high-risk patients with gestational trophoblastic tumours (1979-1984)E S Newlands, K D Bagshawe, R H Begent, et al.British Journal of Cancer|May 1, 1988
A negative phase II trial methylene dimethane sulphonate in advanced ovarian cancer (Cancer Research Campaign Phase I/II Trials Committee)D B Smith, M J Lind, S B Kaye, et al.European Journal of Cancer (Oxford, England : 1990)|September 23, 2000
Surveillance for stage I testicular germ cell tumours: results and cost benefit analysis of management optionsR Francis, M Bower, G Brunström, et al.Histopathology|July 29, 2004
p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancyN J Sebire, H C Rees, D Peston, et al.European Journal of Cancer (Oxford, England : 1990)|May 1, 1997
POMB/ACE chemotherapy for mediastinal germ cell tumoursM Bower, C Brock, L Holden, et al.Anti-Cancer Drug Design|August 14, 1998
Antitumour polycyclic acridines. Part 4. Physico-chemical studies on the interactions between DNA and novel tetracyclic acridine derivativesE Giménez-Arnau, S Missailidis, M F StevensAnti-Cancer Drug Design|April 3, 1998
Antitumour polycyclic acridines. Part 2. Physicochemical studies on the interactions between DNA and novel polycyclic acridine derivativesE Giménez-Arnau, S Missailidis, M F StevensBritish Journal of Cancer|July 1, 1985
Antitumour imidazotetrazines, Part IX. The pharmacokinetics of mitozolomide in miceC Goddard, J A Slack, M F StevensPageof 23